NCT00193167View on ClinicalTrials.gov

Weekly Topotecan in Patients Treated for Metastatic Colorectal Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions

Colon Cancer

Interventions

DRUG

Topotecan

Trial Locations (1)

37203

Tennessee Oncology, Nashville

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

SCRI Development Innovations, LLC

OTHER